Search results
We partner with hospitals and healthcare systems to reduce complexity through life-enhancing solutions, including sterile injectable and ready-to-use products. Together, we innovate to add value where it matters—from manufacturing to treatment—so healthcare providers can focus on patient care.
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system.
Apr 23, 2024 · Endo, Inc. Completes Acquisition of Endo International plc's Assets. Newly Formed Company Poised for Sustained Growth With a Strengthened Balance Sheet, Resolved Litigation Overhang, Diversified Portfolio of Medicines and a Deep New Product Pipeline.
Apr 11, 2024 · Endo Launches Enhanced TruDelivery® Ready-to-Use Product Line and Platform. April 23, 2024. Endo, Inc. Completes Acquisition of Endo International plc's Assets. April 22, 2024. Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution. April ...
May 15, 2024 · Endo Provides Select First-Quarter 2024 Financial Results for Endo International plc
Discover the history of Endo International, a global pharmaceutical company with a diverse portfolio of medicines and a commitment to innovation.
Mar 19, 2024 · Bankrupt drugmaker Endo International won court approval on a Chapter 11 exit plan that cuts debt, settles government claims and resolves thousands of lawsuits accusing the company of helping...
Mar 19, 2024 · March 19 (Reuters) - Bankrupt drugmaker Endo International said on Tuesday a U.S. Bankruptcy Court has approved its restructuring plan and related opioid settlements to emerge from bankruptcy,...
Apr 11, 2024 · Investor and Media Overview. Endo (ENDPQ) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies.
Mar 19, 2024 · Bankrupt drugmaker Endo International won court approval on a Chapter 11 exit plan that cuts debt, settles government claims and resolves thousands of lawsuits accusing the company of helping fuel the US opioid epidemic.
